DNA demethylation and histone H3K9 acetylation determine the active transcription of the NKG2D gene in human CD8⁺ T and NK cells

References

• Glienke J, Sobanov Y, Brostjan C, Steffens C, Nguyen C, Lehrach H, et al. The genomic organization of NKG2C, E, F, and D receptor genes in the human natural killer gene complex. Immunogenetics 1998; 48:163 - 73; http://dx.doi.org/10.1007/s002510050420; PMID: 9683661
   PubMed Web of Science ®Google Scholar
• López-Larrea C, Suárez-Alvarez B, López-Soto A, López-Vázquez A, Gonzalez S. The NKG2D receptor: sensing stressed cells. Trends Mol Med 2008; 14:179 - 89; http://dx.doi.org/10.1016/j.molmed.2008.02.004; PMID: 18353724
   PubMed Web of Science ®Google Scholar
• Maccalli C, Scaramuzza S, Parmiani G. TNK cells (NKG2D+ CD8+ or CD4+ T lymphocytes) in the control of human tumors. Cancer Immunol Immunother 2009; 58:801 - 8; http://dx.doi.org/10.1007/s00262-008-0635-x; PMID: 19089424
   PubMed Web of Science ®Google Scholar
• Fasth AE, Björkström NK, Anthoni M, Malmberg KJ, Malmström V. Activating NK-cell receptors co-stimulate CD4(+)CD28(-) T cells in patients with rheumatoid arthritis. Eur J Immunol 2010; 40:378 - 87; http://dx.doi.org/10.1002/eji.200939399; PMID: 19904767
   PubMed Web of Science ®Google Scholar
• Pariente B, Mocan I, Camus M, Dutertre CA, Ettersperger J, Cattan P, et al. Activation of the receptor NKG2D leads to production of Th17 cytokines in CD4+ T cells of patients with Crohn’s disease. Gastroenterology 2011; 141:217 - 26, 226, e1-2; http://dx.doi.org/10.1053/j.gastro.2011.03.061; PMID: 21600899
   PubMed Web of Science ®Google Scholar
• Li WX, Pan HF, Hu JL, Wang CZ, Zhang N, Li J, et al. Assay of T- and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus. Clin Rheumatol 2010; 29:315 - 23; http://dx.doi.org/10.1007/s10067-009-1322-9; PMID: 20012119
   PubMed Web of Science ®Google Scholar
• de Menthon M, Lambert M, Guiard E, Tognarelli S, Bienvenu B, Karras A, et al. Excessive interleukin-15 transpresentation endows NKG2D+CD4+ T cells with innate-like capacity to lyse vascular endothelium in granulomatosis with polyangiitis (Wegener’s). Arthritis Rheum 2011; 63:2116 - 26; http://dx.doi.org/10.1002/art.30355; PMID: 21484763
   PubMed Web of Science ®Google Scholar
• Sáez-Borderías A, Gumá M, Angulo A, Bellosillo B, Pende D, López-Botet M. Expression and function of NKG2D in CD4+ T cells specific for human cytomegalovirus. Eur J Immunol 2006; 36:3198 - 206; http://dx.doi.org/10.1002/eji.200636682; PMID: 17109473
   PubMed Web of Science ®Google Scholar
• Wang Y, Bai J, Li F, Wang H, Fu X, Zhao T, et al. Characteristics of expanded CD4+CD28null T cells in patients with chronic hepatitis B. Immunol Invest 2009; 38:434 - 46; http://dx.doi.org/10.1080/08820130902943105; PMID: 19811419
   PubMed Web of Science ®Google Scholar
• Alonso-Arias R, Moro-García MA, López-Vázquez A, Rodrigo L, Baltar J, García FM, et al. NKG2D expression in CD4+ T lymphocytes as a marker of senescence in the aged immune system. Age (Dordr) 2011; 33:591 - 605; http://dx.doi.org/10.1007/s11357-010-9200-6; PMID: 21210234
   PubMed Web of Science ®Google Scholar
• Meresse B, Chen Z, Ciszewski C, Tretiakova M, Bhagat G, Krausz TN, et al. Coordinated induction by IL-15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 2004; 21:357 - 66; http://dx.doi.org/10.1016/j.immuni.2004.06.020; PMID: 15357947
   PubMed Web of Science ®Google Scholar
• Muntasell A, Magri G, Pende D, Angulo A, López-Botet M. Inhibition of NKG2D expression in NK cells by cytokines secreted in response to human cytomegalovirus infection. Blood 2010; 115:5170-9.
   Google Scholar
• Ventre E, Brinza L, Schicklin S, Mafille J, Coupet CA, Marçais A, et al. Negative regulation of NKG2D expression by IL-4 in memory CD8 T cells. J Immunol 2012; 189:3480 - 9; http://dx.doi.org/10.4049/jimmunol.1102954; PMID: 22942430
   PubMed Web of Science ®Google Scholar
• Groh V, Wu J, Yee C, Spies T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 2002; 419:734 - 8; http://dx.doi.org/10.1038/nature01112; PMID: 12384702
   PubMed Web of Science ®Google Scholar
• Peraldi MN, Berrou J, Dulphy N, Seidowsky A, Haas P, Boissel N, et al. Oxidative stress mediates a reduced expression of the activating receptor NKG2D in NK cells from end-stage renal disease patients. J Immunol 2009; 182:1696 - 705; PMID: 19155520
   PubMed Web of Science ®Google Scholar
• Della Chiesa M, Carlomagno S, Frumento G, Balsamo M, Cantoni C, Conte R, et al. The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function. Blood 2006; 108:4118 - 25; http://dx.doi.org/10.1182/blood-2006-03-006700; PMID: 16902152
   PubMed Web of Science ®Google Scholar
• Burgess SJ, Marusina AI, Pathmanathan I, Borrego F, Coligan JE. IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells. J Immunol 2006; 176:1490 - 7; PMID: 16424177
   PubMed Web of Science ®Google Scholar
• Espinoza JL, Takami A, Yoshioka K, Nakata K, Sato T, Kasahara Y, et al. Human microRNA-1245 down-regulates the NKG2D receptor in natural killer cells and impairs NKG2D-mediated functions. Haematologica 2012; 97:1295 - 303; http://dx.doi.org/10.3324/haematol.2011.058529; PMID: 22491735
   PubMed Web of Science ®Google Scholar
• González S, López-Soto A, Suarez-Alvarez B, López-Vázquez A, López-Larrea C. NKG2D ligands: key targets of the immune response. Trends Immunol 2008; 29:397 - 403; http://dx.doi.org/10.1016/j.it.2008.04.007; PMID: 18602338
   PubMed Web of Science ®Google Scholar
• Eagle RA, Traherne JA, Hair JR, Jafferji I, Trowsdale J. ULBP6/RAET1L is an additional human NKG2D ligand. Eur J Immunol 2009; 39:3207 - 16; http://dx.doi.org/10.1002/eji.200939502; PMID: 19658097
   PubMed Web of Science ®Google Scholar
• Smyth MJ, Swann J, Cretney E, Zerafa N, Yokoyama WM, Hayakawa Y. NKG2D function protects the host from tumor initiation. J Exp Med 2005; 202:583 - 8; http://dx.doi.org/10.1084/jem.20050994; PMID: 16129707
   PubMed Web of Science ®Google Scholar
• Zloza A, Lyons GE, Chlewicki LK, Kohlhapp FJ, O’Sullivan JA, Lacek AT, et al. Engagement of NK receptor NKG2D, but not 2B4, results in self-reactive CD8+ T cells and autoimmune vitiligo. Autoimmunity 2011; 44:599 - 606; http://dx.doi.org/10.3109/08916934.2011.593599; PMID: 21913803
   PubMed Web of Science ®Google Scholar
• Suárez-Álvarez B, Fernández-Sánchez A, López-Vázquez A, Coto E, Ortega F, López-Larrea C. NKG2D and its ligands: active factors in the outcome of solid organ transplantation?. Kidney Int Suppl 2011; 1:52 - 7; http://dx.doi.org/10.1038/kisup.2011.13
   Google Scholar
• Kaplan MJ, Lu Q, Wu A, Attwood J, Richardson B. Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells. J Immunol 2004; 172:3652 - 61; PMID: 15004168
   PubMed Web of Science ®Google Scholar
• Kersh EN, Fitzpatrick DR, Murali-Krishna K, Shires J, Speck SH, Boss JM, et al. Rapid demethylation of the IFN-gamma gene occurs in memory but not naive CD8 T cells. J Immunol 2006; 176:4083 - 93; PMID: 16547244
   PubMed Web of Science ®Google Scholar
• Akimzhanov AM, Yang XO, Dong C. Chromatin remodeling of interleukin-17 (IL-17)-IL-17F cytokine gene locus during inflammatory helper T cell differentiation. J Biol Chem 2007; 282:5969 - 72; http://dx.doi.org/10.1074/jbc.C600322200; PMID: 17218320
   PubMed Web of Science ®Google Scholar
• Li G, Yu M, Weyand CM, Goronzy JJ. Epigenetic regulation of killer immunoglobulin-like receptor expression in T cells. Blood 2009; 114:3422 - 30; http://dx.doi.org/10.1182/blood-2009-01-200170; PMID: 19628706
   PubMed Web of Science ®Google Scholar
• Juelich T, Sutcliffe EL, Denton A, He Y, Doherty PC, Parish CR, et al. Interplay between chromatin remodeling and epigenetic changes during lineage-specific commitment to granzyme B expression. J Immunol 2009; 183:7063 - 72; http://dx.doi.org/10.4049/jimmunol.0901522; PMID: 19915065
   PubMed Web of Science ®Google Scholar
• Xiao Y, Li B, Zhou Z, Hancock WW, Zhang H, Greene MI. Histone acetyltransferase mediated regulation of FOXP3 acetylation and Treg function. Curr Opin Immunol 2010; 22:583 - 91; http://dx.doi.org/10.1016/j.coi.2010.08.013; PMID: 20869864
   PubMed Web of Science ®Google Scholar
• Garcia-Manero G, Fenaux P. Hypomethylating agents and other novel strategies in myelodysplastic syndromes. J Clin Oncol 2011; 29:516 - 23; http://dx.doi.org/10.1200/JCO.2010.31.0854; PMID: 21220589
   PubMed Web of Science ®Google Scholar
• Kang J, Chen J, Shi Y, Jia J, Zhang Y. Curcumin-induced histone hypoacetylation: the role of reactive oxygen species. Biochem Pharmacol 2005; 69:1205 - 13; http://dx.doi.org/10.1016/j.bcp.2005.01.014; PMID: 15794941
   PubMed Web of Science ®Google Scholar
• Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999; 285:727 - 9; http://dx.doi.org/10.1126/science.285.5428.727; PMID: 10426993
   PubMed Web of Science ®Google Scholar
• Suárez-Alvarez B, López-Vázquez A, Díaz-Molina B, Bernardo-Rodríguez MJ, Alvarez-López R, Pascual D, et al. The predictive value of soluble major histocompatibility complex class I chain-related molecule A (MICA) levels on heart allograft rejection. Transplantation 2006; 82:354 - 61; http://dx.doi.org/10.1097/01.tp.0000228911.22944.23; PMID: 16906033
   PubMed Web of Science ®Google Scholar
• Araki Y, Fann M, Wersto R, Weng NP. Histone acetylation facilitates rapid and robust memory CD8 T cell response through differential expression of effector molecules (eomesodermin and its targets: perforin and granzyme B). J Immunol 2008; 180:8102 - 8; PMID: 18523274
   PubMed Web of Science ®Google Scholar
• Liu Y, Kuick R, Hanash S, Richardson B. DNA methylation inhibition increases T cell KIR expression through effects on both promoter methylation and transcription factors. Clin Immunol 2009; 130:213 - 24; http://dx.doi.org/10.1016/j.clim.2008.08.009; PMID: 18945643
   PubMed Web of Science ®Google Scholar
• Liu Y, Chen Y, Richardson B. Decreased DNA methyltransferase levels contribute to abnormal gene expression in “senescent” CD4(+)CD28(-) T cells. Clin Immunol 2009; 132:257 - 65; http://dx.doi.org/10.1016/j.clim.2009.03.529; PMID: 19394279
   PubMed Web of Science ®Google Scholar
• Balasubramanyam K, Varier RA, Altaf M, Swaminathan V, Siddappa NB, Ranga U, et al. Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J Biol Chem 2004; 279:51163 - 71; http://dx.doi.org/10.1074/jbc.M409024200; PMID: 15383533
   PubMed Web of Science ®Google Scholar
• Gao XN, Lin J, Wang LL, Yu L. Demethylating treatment suppresses natural killer cell cytolytic activity. Mol Immunol 2009; 46:2064 - 70; http://dx.doi.org/10.1016/j.molimm.2009.02.033; PMID: 19394699
   PubMed Web of Science ®Google Scholar
• Schmiedel BJ, Arélin V, Gruenebach F, Krusch M, Schmidt SM, Salih HR. Azacytidine impairs NK cell reactivity while decitabine augments NK cell responsiveness toward stimulation. Int J Cancer 2011; 128:2911 - 22; http://dx.doi.org/10.1002/ijc.25635; PMID: 20960460
   PubMed Web of Science ®Google Scholar
• Ogbomo H, Michaelis M, Kreuter J, Doerr HW, Cinatl J Jr.. Histone deacetylase inhibitors suppress natural killer cell cytolytic activity. FEBS Lett 2007; 581:1317 - 22; http://dx.doi.org/10.1016/j.febslet.2007.02.045; PMID: 17349632
   PubMed Web of Science ®Google Scholar
• Saikali P, Antel JP, Pittet CL, Newcombe J, Arbour N. Contribution of astrocyte-derived IL-15 to CD8 T cell effector functions in multiple sclerosis. J Immunol 2010; 185:5693 - 703; http://dx.doi.org/10.4049/jimmunol.1002188; PMID: 20926794
   PubMed Web of Science ®Google Scholar
• Tang F, Chen Z, Ciszewski C, Setty M, Solus J, Tretiakova M, et al. Cytosolic PLA2 is required for CTL-mediated immunopathology of celiac disease via NKG2D and IL-15. J Exp Med 2009; 206:707 - 19; http://dx.doi.org/10.1084/jem.20071887; PMID: 19237603
   PubMed Web of Science ®Google Scholar
• Ito A, Shimura H, Nitahara A, Tomiyama K, Ito M, Kanekura T, et al. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway. Int Immunol 2008; 20:1343 - 9; http://dx.doi.org/10.1093/intimm/dxn092; PMID: 18697765
   PubMed Web of Science ®Google Scholar
• Feng L, Ke N, Ye Z, Guo Y, Li S, Li Q, et al. Expression of NKG2D and its ligand in mouse heart allografts may have a role in acute rejection. Transplant Proc 2009; 41:4332 - 9; http://dx.doi.org/10.1016/j.transproceed.2009.08.060; PMID: 20005394
   PubMed Web of Science ®Google Scholar
• Joshi M, Dindelegan G, Olausson M, Oltean M. Natural killer group 2 member D cell recruitment driven by major histocompatibility complex class I chain-related antigens A and B: a possible mechanism during acute intestinal allograft rejection in the mouse. Transplant Proc 2010; 42:4467 - 9; http://dx.doi.org/10.1016/j.transproceed.2010.09.115; PMID: 21168719
   PubMed Web of Science ®Google Scholar
• Gannagé M, Buzyn A, Bogiatzi SI, Lambert M, Soumelis V, Dal Cortivo L, et al. Induction of NKG2D ligands by gamma radiation and tumor necrosis factor-alpha may participate in the tissue damage during acute graft-versus-host disease. Transplantation 2008; 85:911 - 5; http://dx.doi.org/10.1097/TP.0b013e31816691ef; PMID: 18360276
   PubMed Web of Science ®Google Scholar
• Ogasawara K, Hamerman JA, Ehrlich LR, Bour-Jordan H, Santamaria P, Bluestone JA, et al. NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity 2004; 20:757 - 67; http://dx.doi.org/10.1016/j.immuni.2004.05.008; PMID: 15189740
   PubMed Web of Science ®Google Scholar
• Ito Y, Kanai T, Totsuka T, Okamoto R, Tsuchiya K, Nemoto Y, et al. Blockade of NKG2D signaling prevents the development of murine CD4+ T cell-mediated colitis. Am J Physiol Gastrointest Liver Physiol 2008; 294:G199 - 207; http://dx.doi.org/10.1152/ajpgi.00286.2007; PMID: 17962357
   PubMed Web of Science ®Google Scholar
• Andersson AK, Sumariwalla PF, McCann FE, Amjadi P, Chang C, McNamee K, et al. Blockade of NKG2D ameliorates disease in mice with collagen-induced arthritis: a potential pathogenic role in chronic inflammatory arthritis. Arthritis Rheum 2011; 63:2617 - 29; http://dx.doi.org/10.1002/art.30460; PMID: 21618462
   PubMed Web of Science ®Google Scholar
• Ogasawara K, Benjamin J, Takaki R, Phillips JH, Lanier LL. Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts. Nat Immunol 2005; 6:938 - 45; http://dx.doi.org/10.1038/ni1236; PMID: 16086018
   PubMed Web of Science ®Google Scholar
• Li J, Zhu H, Wang S, Ye P, Liu C, Wu J, et al. Blockade of NKG2D synergized with CTLA4-Ig in promoting long-term graft survival in murine models of cardiac transplantation. Transplantation 2012; 93:356 - 63; http://dx.doi.org/10.1097/TP.0b013e31823ffce7; PMID: 22179404
   PubMed Web of Science ®Google Scholar
• Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000; 132:365 - 86; PMID: 10547847
   PubMedGoogle Scholar
• Kottilil S, Shin K, Jackson JO, Reitano KN, O’Shea MA, Yang J, et al. Innate immune dysfunction in HIV infection: effect of HIV envelope-NK cell interactions. J Immunol 2006; 176:1107 - 14; PMID: 16393999
   PubMed Web of Science ®Google Scholar
• Suárez-Alvarez B, Rodriguez RM, Calvanese V, Blanco-Gelaz MA, Suhr ST, Ortega F, et al. Epigenetic mechanisms regulate MHC and antigen processing molecules in human embryonic and induced pluripotent stem cells. PLoS One 2010; 5:e10192; http://dx.doi.org/10.1371/journal.pone.0010192; PMID: 20419139
   PubMedGoogle Scholar